Indian rupee extends slide on foreign outflows, dollar demand from oil firms
The rupee closed at 87.6550 to the dollar, compared with Friday's close of 87.5400.
The currency had opened stronger at 87.2250, tracking a weaker dollar after a softer-than-expected U.S. jobs report on Friday raised expectations of a Federal Reserve rate cut in September.
The dollar index was down 0.27% at 98.92 as of 1025 GMT.
However, dollar-buying through the day, especially by oil importers, erased early gains, traders said.
The rupee had dropped to 87.74 last Thursday, its lowest since February and just shy of its record low of 87.95, following former U.S. President Donald Trump's announcement of a steeper-than-expected 25% tariff on Indian imports.
Indian rupee suffers worst monthly drop since 2022 on tariff blow, portfolio outflows
The Reserve Bank of India intervened through the week to support the currency, traders said.
'Consistent foreign outflows from local stocks and elevated corporate dollar demand are likely to keep the rupee under pressure,' a trader at a private bank said.
Foreign investors sold $2 billion worth of Indian equities on a net basis in July.
Despite intraday volatility, the rupee may stabilise in the coming days, said Dilip Parmar, foreign exchange analyst at HDFC Securities.
The RBI's rate decision at its monetary policy meeting later this week could also influence the local currency's trajectory, Parmar added.
Meanwhile, other Asian currencies gained on Monday, led by the Malaysian ringgit's rebound of nearly 1% as dollar weakness offered relief from recent losses.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Recorder
4 minutes ago
- Business Recorder
US tariff threat to keep Indian rupee on the ropes ahead of RBI rate call
MUMBAI: The Indian rupee is likely to remain under pressure ahead of the central bank's interest rate decision on Wednesday, after nearing an all-time low following President Donald Trump's fresh threats of steep tariffs on Indian goods. The 1-month non-deliverable forward suggests the rupee will open slightly weaker against the U.S. dollar from Tuesday's level of 87.80. The currency dropped as much as 87.8850 on Tuesday, just shy of its record low of 87.95 hit in February. Bankers said the rupee avoided hitting a fresh lifetime low, thanks to likely dollar sales by the Reserve Bank of India through state-run banks. The central bank had to step in after the rupee slid following Trump's threat of substantial tariffs on Indian goods over Russian oil purchases. 'The RBI probably wanted to avoid headlines about the rupee hitting a new low on the same day Trump was ramping up tariffs,' an FX trader at a private bank said. '87.90–88 is the key zone to watch. If the RBI does cut rates today, we'll most likely break past that, and the central bank may allow some weakness.' About three-quarters of the 57 participants in a Reuters poll expect the RBI to leave the policy rate unchanged at 5.50%. The rest anticipate a 25-basis point cut, following a larger-than-expected 50-bp reduction in June. Citibank, ANZ, DBS, State Bank of India and ICICI Bank are among those expecting a rate cut. At the previous policy, SBI was the only one to predict a 50-bps reduction. Monetary policy operates with lags, and postponing a rate cut until inflation falls further or growth weakens more visibly could result in deeper and more persistent economic damage, SBI said in a note. 'We expect RBI to continue frontloading with a 25 bps cut in August policy.'
Business Recorder
4 minutes ago
- Business Recorder
Indian shares set to open flat ahead of RBI policy decision
Indian shares are set to open little changed on Wednesday ahead of the Reserve Bank of India's (RBI) policy announcement, with investors anticipating a rate pause and dovish signals to offset rising external risks, particularly the proposed U.S. tariffs. Gift Nifty futures were trading at 24,670 points as of 7:04 a.m. IST, indicating that the Nifty 50 (.NSEI), opens new tab will open near Tuesday's close of 24,649.55. The RBI is widely expected to hold rates steady at its policy decision scheduled at 10:00 a.m. IST, following its surprise 50-basis-point cut in June, which was accompanied by a shift to a 'neutral' stance. While the central bank had previously signalled limited room for further easing, expectations for the reassurance of growth and dovish commentary have intensified following the U.S.'s 25% tariffs on Indian goods. 'In light of the proposed U.S. tariffs, markets will be looking for a dovish tone and clear reassurance on growth support,' said Gaurav Garg, analyst at Lemonn Markets Desk. 'The Governor's guidance on balancing domestic demand with external headwinds will be key.' Since the June 6 policy, the Nifty 50 has slipped 1.41%, weighed down by muted earnings and global uncertainty. Foreign portfolio investors were net sellers for 12 straight sessions till Tuesday, reacting to trade concerns and earnings disappointment. Meanwhile, domestic institutional investors sold stocks in 22 sessions, providing some cushion to FPI outflows. 'The sustained FPI selling was largely driven by a combination of subdued Q1 earnings, a strong U.S. dollar and uncertainty surrounding the U.S-India trade negotiations,' said Manish Goel, founder and managing director at Equentis Wealth Advisory Services. FPI outflows may continue till there is greater clarity on trade policy and an improvement in corporate earnings, Goel added. Broader Asian markets opened lower, while Wall Street declined overnight as investors weighed tariff concerns and weaker than expected U.S. economic data.
Business Recorder
4 minutes ago
- Business Recorder
US to initially impose ‘small tariff' on pharma imports, Trump says
WASHINGTON: President Donald Trump said on Tuesday that the United States would initially place a 'small tariff' on pharmaceutical imports before hiking it to 150% within 18 months and eventually to 250% in an effort to boost domestic production. 'In one year, one and a half years maximum, it's going to go to 150% and then it's going to go to 250% because we want pharmaceuticals made in our country,' Trump told CNBC in an interview. He did not specify the initial tariff rate on pharmaceuticals. Trump said last month that pharmaceutical tariffs could reach as high as 200%. He said in February that sectoral tariffs on pharmaceuticals and semiconductor chips would start at '25% or higher,' rising substantially over the course of a year. Trump said on Tuesday that he plans to announce tariffs on semiconductors and chips in the 'next week or so,' but gave no further details. The United States has been conducting a national security review of the pharmaceutical sector, and the industry has been preparing for possible sector-specific tariffs. The administration has not announced when the results of that probe will be released. Several drugmakers have pledged multibillion-dollar investments in US manufacturing as Trump threatens import tariffs, with AstraZeneca recently committing $50 billion to expand its American operations. PhRMA, the main lobbying group for the industry, did not immediately respond to a request for comment. A framework agreement between the United States and the EU sets out that tariffs on pharmaceuticals and semiconductors are currently zero, but if the United States raises tariffs following its import investigation, they will be capped at 15%.
